On Television
Our Locations
- Pennsylvania Address
(215) 772-1000 - New Jersey Address
(856) 662-1180 - New York Address
(212) 986-6200 - Google Map
Mass Tort Lawyer
Philadelphia, Pennsylvania, New Jersey and New York

Kline & Specter, P.C. is a recognized leader in pharmaceutical and product liability litigation.
The firm's Mass Tort Department handles cases involving a litany of drugs - from Abilify to Zyprexa, from Accutane to Viagra and Vioxx. It also litigates cases involving a wide range of other products, such as asbestos, defective pacemakers and defibrillators and Bausch & Lomb ReNu brand contact lens solution. (See lists below.)
Kline & Specter, P.C., is among the handful of law firms spearheading national litigation against Merck & Co. involving the pain medication Vioxx which was removed from the market in 2004 after it was linked to an increased risk of heart attacks and strokes. Tom Kline and Shanin Specter deposed ranking Merck executives and scientists. Kline is also a member of the Plaintiff’s Steering Committee directing the federal Vioxx litigation.
Heading the mass tort litigation team for Kline & Specter is Lee B. Balefsky, a partner at Kline & Specter, who has 30 years experience in complex litigation. (continued below)
Pharmaceuticals:
Medical Devices and Other Products:
| Asbestos/Mesothelioma | Guidant Defibrillators |
| Baxter Medicine Pumps | Hernia Mesh Patch (Kugel) |
| Bausch & Lomb lens solution | Medtronic Defibrillators/Leads |
| Bone Cement | MRI Scanners |
| Chinese Products | MTBE (Methyl Tertiary Butyl Ether) |
| Complete Moisture Plus lens solution | Norian XR |
| Contrast Dyes | Optison contrast agent |
| Dangerous Toys | Pain Pumps |
| Defective Children's Products | Pacemakers |
| Defective Hospital Beds | Pesticides - Dursban |
| Defective Medical Devices | Poligrip |
| Definity contrast agent | ReNu with MoistureLoc lens solution |
| Dursban pesticide | Shoulder pain pumps |
| Gadolinium | Stents |
| Surgical Staples |
Beyond being a national leader in the Vioxx litigation, Kline & Specter has had more than 1,000 clients in the Fen-Phen diet drugs case.
Lee Balefsky serves as the Philadelphia County Mass Tort Program liaison counsel in the Vioxx, Diet Drugs, and PPA cases, a role in which he aids the court in case management while providing information to other attorneys involved in the cases. The Mass Tort Department has achieved significant settlements for in lawsuits against the makers of several drugs, including Baycol, Fen-Phen and PPA.
The Mass Tort Department's expertise goes far beyond pharmaceutical cases. Balefsky has won numerous cases over the past two decades for clients stricken with cancer because of asbestos inhalation, a still-present danger. The division also handles cases involving defective medical devices and is currently representing a water company in a case involving MTBE, a gasoline additive that works its way into water supplies.
Although clients are individually represented in mass tort cases, the system allows for consolidation and streamlining by allowing lawyers for numerous clients to "pool" discovery. Numerous witness depositions and document gathering can be conducted once, with the information centralized and shared among the parties for each individual trial or settlement negotiation.
The firm handles cases in Pennsylvania, New Jersey and New York. For cases outside those states, Kline & Specter works with local attorneys in each state as applicable.
For more information on mass tort litigation, see the article co-authored by Michelle Tiger titled "Philadelphia Mass Tort Program: Alive and Well" and published in the February 2005 issue of Product Liability Law & Strategy.
News
- Tom Kline comments on increased Mass Torts drug cases, The legal Intelligencer 3/19/09 (Full story)
- Tom Kline speaks out on FDA drug labeling policy
- Johnson & Johnson has spent at least $68.7 million to settle hundreds of lawsuits filed by women who suffered blood clots, heart attacks or strokes after using the Ortho Evra birth-control patch. In the product liability case, complaints filed on behalf of 4,000 women in state and federal courts claim the company hid or altered data about the risks of high levels of estrogen released by the patch. (Full story)
- Pfizer Inc. finalizes part of a larger, $894 million deal to settle personal injury lawsuits over its promotion of the painkillers Celebrex and discontinued Bextra. The company will pay $60 million to settle investigations by 33 states and Washington, D.C., over Bextra, and has agreed to adopt compliance measures. Various states alleged Pfizer promoted the painkiller for uses it was not approved for. The company said it would pay $745 million to settle personal injury cases, $60 million to settle with attorneys general in the 33 states and Washington, D.C., and $89 million to cover consumer fraud class action cases over reimbursement for money spent on the two drugs. (Full story)
- A study by Merck of its pain reliever Arcoxia showed similar risks of heart attacks and other cardiovascular problems compared with another painkiller, diclofenac, federal reviewers said in an analysis made public Tuesday. (Full story.)





























